ロング
200% XENT
After conducting the research, I invested in and made over 200% on (XTLB) & (EYES), short % of float has been reduced to less than 1% of outstanding shares short currently.
Now investing in (XENT), has a short % of float of 6x larger (6.25%), total of 1,050,000 shares short, so may see an even lager gain.
Ears, Nose, Throat Devices Market to reach $26BB, with cumulative impact of COVID-19 SARS CoV2 variants, bio-absorbable therapies such as Propel & Sinuva fastest growing segment.
(See market report below)
(XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in Revenue, at comp. 10X Sales= $200 per share
(XENT) Intersect ENT Inc.
- Positive 10 day & 50 day Moving Average
- Current Assets to Liabilities ratio attractive
- Enterprise Value is undervalued compared to peer group
- 5 Day Rounding Bottom chart + (Cup & Handle)
- Moving Average Convergence Divergence crossing higher.
Christopher Michael Lim, MSc. Health Sciences
Western University Medical
Now investing in (XENT), has a short % of float of 6x larger (6.25%), total of 1,050,000 shares short, so may see an even lager gain.
Ears, Nose, Throat Devices Market to reach $26BB, with cumulative impact of COVID-19 SARS CoV2 variants, bio-absorbable therapies such as Propel & Sinuva fastest growing segment.
(See market report below)
(XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in Revenue, at comp. 10X Sales= $200 per share
(XENT) Intersect ENT Inc.
- Positive 10 day & 50 day Moving Average
- Current Assets to Liabilities ratio attractive
- Enterprise Value is undervalued compared to peer group
- 5 Day Rounding Bottom chart + (Cup & Handle)
- Moving Average Convergence Divergence crossing higher.
Christopher Michael Lim, MSc. Health Sciences
Western University Medical
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。